[1] HUI L, YUAN Y, WANG ZH, et al.Clinical efficacy of parecoxib sodium in patients with hepatocellular carcinoma after hepatectomy[J]. Journal of Pharmaceutical Practice(药学实践杂志), 2017, 35(1): 73-74,81. [2] Aspect of pharmaceutical affairs. Yesterday added newcomer, cloth products market pattern quietly[EB/OL]. (2019-10-25)[2020-01-20].https://mp.weixin.qq.com/s/lr0fce464oXn6mVMtCxETg. [3] WANG RR, RAO YF, YU Z, et al.Retrospective study on the use of nonsteroidal anti-inflammatory drugs during perioperative period[J]. Chinese Journal of Pharmacy(中国药学杂志), 2019, 54(13): 1104-1108. [4] FENG YN, LIU XX, LI YH, et al.Pharmacovigilance in medical institutions under the new Drug Administration Law[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(9): 572-573,582. [5] REN XD, ZHANG L, WEI YX, et al.Ambivalence of drug instructions and countermeasures[J]. China Pharmacy(中国药房), 2015, 26(22): 3150-3152. [6] China Judicial Process Information Online. Provisions on People's Courts Publishing Judgments on the Internet[EB/OL]. (2016-08-31)[2021-03-01]. https://splcgk.court.gov.cn/gzfwww/sfjs/details?id=8b658418b1c14cf5beceb2eb815ce87f. [7] The Supreme People's Court of the People's Republic of China. China Judgements Online[EB/OL].[2021-03-01]. https://wenshu.court.gov.cn/. [8] LIU L, FAN Z.Clinical application of drug instruction from the perspective of law[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2020, 36(4): 456-457, 461. [9] The Supreme People's Court of the People's Republic of China. China Judgements Online[EB/OL].[2016-10-31]. https://wenshu.court.gov.cn/. [10] The Supreme People's Court of the People's Republic of China. China Judgements Online[EB/OL].[2019-03-05]. https://wenshu.court.gov.cn/. [11] XU JG.A general consensus on the management of postoperative pain in adults[J].Journal of Clinical Anesthesiology(临床麻醉学杂志), 2017, 33(9): 911-917. [12] Guangdong Pharmaceutical Society.Guidelines for postoperative pain management of clinical pharmacists[J]. Today Pharmacy(今日药学), 2019, 29(4): 217-227. [13] National Health and Family Planning Commission Rational Drug Use Expert Committee, Chinese Pharmacists Association. Guidelines for Rational Drug Use in Coronary Heart Disease(冠心病合理用药指南)[M]. Beijing : People's Health Publishing House, 2016. [14] DENG DY, SU YX.Empirical prospect and ideal construction of“judgment-centered”- from the analytical perspective of 2185 criminal judgment documents[J]. Sun Yat-sen University Law Review(中山大学法律评论), 2018 (2):135-152. [15] YU Y, LIU DL, CHEN F, et al.Analysis and intervention of unreasonable medical order in endocrine inpatients[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(12): 921-925,933. [16] GUO F, LI T, SUN RJ, et al.The effect of pharmaceutical intervention on the use of second class psychotropic drugs in a psychiatric hospital[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(9): 550-554, 560. [17] CHEN HM, JIA HF, LYU LY, et al.Effects of dexmedetomidine combined with parecoxib on postoperative inflammatory factors and intestinal mucosal barrier function in elderly patients with severe pancreatitis[J]. Chinese Journal of Gerontology(中国老年学), 2019, 39(4): 83-85. [18] ZHANG YQ, SONG HJ, WANG ZD.Effect of somatostatin and esomeprazole on the treatment of upper gastrointestinal bleeding[J]. Modern Medicine and Clinical Practice(现代药物与临床), 2017, 32(3): 455-459. [19] YUAN W, CHEN X, LIU Y, et al.Evaluation of safety of Agkistrodon agkistrodon hemagglutinase in otolaryngology head and neck surgery[J].Chinese Journal of Medical Guide(中国医药导刊), 2015, 17(4): 366-368. [20] LI CT, HU XD, CHEN G, et al.Comparison of hemostatic efficacy and safety of Agkistrodon agkistrodon hemagglutinase for injection in hepatectomy[J]. Chongqing Medical Science(重庆医学), 2017, 46(8): 1070-1072, 1075. |